SCHEMBL13052284

SCHEMBL13052284

C=COCCOc1c(C)cc([S+](c2ccccc2)c2ccccc2)cc1C

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.33
HTR7 P34969 2/20 0.33
HTR1A P08908 1/20 0.33
ADRA1A P35348 1/20 0.33
HTR6 P50406 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
SCN8A Q9UQD0 2/20 0.32
ATM Q13315 1/20 0.32
SCN4A P35499 2/20 0.31
LMNA P02545 2/20 0.31
MAPT P10636 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL31564932 0.87 GPR3 (0.31)
SCHEMBL13018285 0.84 KDM4E (0.33) MAPTKDM4EALDH1A1
SCHEMBL5117625 0.82
SCHEMBL10170775 0.79 LTA4H (0.46) MEN1KMT2ASCN8AATMLMNA
SCHEMBL13052218 0.78 SCN4A (0.38) HTR2AHTR7HTR1AADRA1AHTR6
Hydrochloric Acid SCHEMBL29816199 0.78 SCN4A (0.36) HTR2AHTR7HTR1AADRA1AHTR6
SCHEMBL2569745 0.77 THRB (0.41) MEN1KMT2ALMNAMAPTL3MBTL1
SCHEMBL8797779 0.77 THRB (0.41) MEN1KMT2ALMNAMAPTL3MBTL1
SCHEMBL98571 0.77 ALDH1A1 (0.41) SCN4AMAPTL3MBTL1KDM4EALDH1A1
SCHEMBL98712 0.77 THRA (0.47) HTR2AHTR1AMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9012129-B2 Resist composition, method of forming resist pattern, novel compound, and acid generator TOKYO OHKA KOGYO CO., LTD. (JO) 2015-04-21 US disclosed
US-8808959-B2 Resist composition, method of forming resist pattern, novel compound, and acid generator TOKYO OHKA KOGYO CO., LTD. (JP) 2014-08-19 US disclosed
US-20140120472-A1 RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, NOVEL COMPOUND, AND ACID GENERATOR TOKYO OHKA KOGYO CO., LTD. (JP) 2014-05-01 US disclosed
US-8415085-B2 Resist composition, method of forming resist pattern, novel compound, and acid generator TOKYO OHKA KOGYO CO., LTD. (JP) 2013-04-09 US disclosed
US-8298748-B2 Positive resist composition, method of forming resist pattern, and polymeric compound TOKYO OHKA KOGYO CO., LTD. (JP) 2012-10-30 US disclosed
US-20120264061-A1 RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, NOVEL COMPOUND, AND ACID GENERATOR TOKYO OHKA KOGYO CO., LTD. (JP) 2012-10-18 US disclosed
US-20100297560-A1 POSITIVE RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, AND POLYMERIC COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2010-11-25 US disclosed
US-20100119974-A1 Resist composition, method of forming resist pattern, novel compound, and acid generator TOKYO OHKA KOGYO CO., LTD. 2010-05-13 US disclosed
US-7396960-B2 Sulfonium salts TOYO GOSEI CO., LTD. (JP) 2008-07-08 US disclosed
US-20070219368-A1 Sulfonium salts TOYO GOSEI CO., LTD. (JP) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264061-A1 RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, NOVEL COMPOUND, AND ACID GENERATOR C1R, RER1, ASIC1 HTR2A 4477/4885HTR7 4639/4885HTR1A 3616/4885
US-20100119974-A1 Resist composition, method of forming resist pattern, novel compound, and acid generator C1R, SCO2, RER1 HTR2A 4463/4885HTR7 4612/4885HTR1A 3776/4885
US-20070219368-A1 Sulfonium salts C1S, F12, C1R HTR2A 3777/4885HTR7 1283/4885HTR1A 2126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.